January 23, 2020
Eli Lilly will invest about $470M and create 460 jobs at their new injectable drug and device plant in Durham, North Carolina. The company expects to […]
January 23, 2020
EQRx, led by veteran biotech venture capitalist Alexis Borisy, is committed to inventing and introducing new drugs at “radically different” prices than what brand-name drugmakers charge. […]
February 6, 2020
Thanks to EvaluatePharma, FiercePharma was able to assemble a list of the top 10 most-anticipated new drug launches of 2020 based on estimated global sales in […]
March 6, 2020
Healthcare executives are keeping their eyes on Amazon, but when KLAS Research asked over 300 healthcare leaders to identify the most potentially disruptive company in healthcare, […]
March 6, 2020
Warren Buffett has bet big on Biogen. Buffet’s Berkshire Hathaway bought 648,447 shares of Biogen at a combined worth of $192.4M near the end of 2019, […]
March 6, 2020
Amid an industrywide price-fixing probe that has caught some of the largest generics players, another former executive faces federal charges––this time from Novartis’ generics unit. […]
March 6, 2020
Frank Reynolds, the founder of Medford biotech PixarBio who claimed his company had developed a painkiller that would replace morphine, was sentenced to seven years in […]
March 6, 2020
Thermo Fisher Scientific plans to acquire Qiagen in a deal valued at $11.5B, putting an end to doubts first voiced last November. The deal is expected […]
April 9, 2020
Xconomy Boston — Based on the latest news and analysis, as well as conversations from industry experts during the Combatting Coronavirus live panel at BIO-Europe Spring®, […]